Plant-based therapeutic agent with virustatic and antiviral effect

• US 5,725,859 A
• Filed: 06/03/1996
• Issued: 03/10/1998
• Est. Priority Date: 05/03/1994
• Status: Expired due to Fees

• Current Assignee: Osama L.M. Omer
• Original Assignee: Osama L.M. Omer
• Inventors: Omer, Osama L.M.
• Primary Examiner(s): Lankford, Jr., Leon B.
• Assistant Examiner(s): TATE, CHRISTOPHER ROBIN
• Application Number:
  US08/586,739
• Time in Patent Office: 645 Days
• Field of Search: 424/195.1, 424/405, 424/404
• US Class Current: 424/740
• CPC Class Codes: A61K 2300/00 Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
• CPC Class Codes: A61K 36/22 Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
• CPC Class Codes: A61K 36/28 Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
• CPC Class Codes: A61K 36/30 Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
• CPC Class Codes: A61K 36/71 Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
• CPC Class Codes: A61K 36/738 Rosa (rose)
• CPC Class Codes: A61K 36/9064 Amomum, e.g. round cardamom

Abstract

A method of treating a patient infected with DNA virus of the herpes family or DNA hepatitis B or hepatitis C viruses, or suffering from chronic allergic rhino-sino-bronchitis, by administering to the said patient a pharmaceutical composition comprising at least two of the compounds selected from the group consisting of absinthe (artemisia absinthium) resin of mastic (resin pistacia lenticus) fruit of delphinium denudatum and wherein one or more of the compounds selected from the group consisting of rose buds (flores rosae) seeds of cardamom (fructus ellettaria cardamomum, and borage flowers (flores onosma brateatum boriginaceae) are added.

Claims

1. A method of treating a patient infected with DNA virus of the herpes family or DNA hepatitis B or hepatitis C viruses, or suffering from chronic allergic rhino-sino-bronchitis, by administering to the said patient a pharmaceutical composition comprising at least two of the compounds selected from the group consisting of

absinthe (artemisia absinthium)

resin of mastic (resin pistacia lenticus)

fruit of delphinium denudatum.

2. The method according to claim 1, wherein the pharmaceutical composition further comprises at least one of the compounds selected from the group consisting of

rose buds (flores rosae)

seeds of cardamom (fructus ellettaria cardamomum)

borage flowers (flores onosma brateatum boriginaceae).

3. A pharmaceutical composition for treating a patient infected with DNA virus of the herpes family or DNA hepatitis B or hepatitis C Viruses, or suffering from chronic allergic rhino-sino-bronchitis, said composition comprising at least two of the compounds selected from the group consisting of absinthe resin of mastic, and fruit of delphinium denudatum.

4. A pharmaceutical composition according to claim 3 wherein the composition further comprises at least one of the compounds selected from the group consisting of buds of roses, seeds of cardamom, and borage flowers.